small routes of administration Subcutaneous Etanercept trade name Enbrel is a drug that treats autoimmune ... as a TNF inhibitor . Etanercept is a fusion protein produced through Gene expression expression ... 2 to IgG1. Production of Etanercept is accomplished by the large scale culturing of cells that have ... in patient reported outcomes for patients with ankylosing spondylitis treated with etanercept ... diseases Nature Medicine accessdate 2008 01 10 work ref In North America, etanercept is co marketed ... excluding Japan where Takeda Pharmaceuticals markets the drug. Etanercept is an example of a protein ... by modern cell biology . Development Etanercept was developed by researchers at Immunex, and was released ... monoclonal antibody against TNF to be marketed for clinical use. Etanercept is a protein dimer ... of its action by etanercept reduces the inflammatory response which is especially useful for treating ..., do not contain TNF receptors on their surface . Etanercept mimics the inhibitory effects of naturally occurring soluble TNF receptors, the difference being that etanercept, because it is a fusion protein ... al. title Study of etanercept, a tumor necrosis factor alpha inhibitor, in recurrent ovarian cancer ... url http jco.ascopubs.org cgi content full 23 25 5950 ref Structure Etanercept is made from ... ENBREL accessdate 2008 01 10 format work ref Although these three agents etanercept, infliximab and adalimumab ... placed a black box warning on etanercept due to a number of serious infections associated with the drug ... diseases, etanercept is being studied as treatment for a number of these disease, including over ... journal author title Etanercept plus standard therapy for Wegener s granulomatosis journal N. Engl ... content.nejm.org cgi content full 352 4 351 author1 Wegener s Granulomatosis Etanercept Trial WGET ... in various cognitive rating scales in patients with Alzheimer s disease AD after treatment with etanercept ... perispinal etanercept administration journal J. Neuroinflammation volume 5 issue 2 pages 2 year ... more details
s disease following perispinal administration of etanercept ref http www.jneuroinflammation.com ... following perispinal etanercept administration Bot generated title ref which has been received ... 5 1 3 Journal of Neuroinflammation Full text Perispinal etanercept Potential as an Alzheimer therapeutic ... 2011, begun enrollment into a randomized, placebo controlled clinical trial of etanercept for patients ... of epidural etanercept for sciatica U.S. patent 6,419,944 issued to Tobinick July 2002 , for which ... the Tumor necrosis factors TNF receptor fusion protein etanercept , for the treatment of certain neurologic ... utility of etanercept , alone or in combination with oseltamivir for treatment of influenza U.S. patent ... of chronic stroke deficits after perispinal etanercept three consecutive cases. journal CNS Drugs ... Tobinick E title Perispinal etanercept a new therapeutic paradigm in neurology journal Expert Review ... X. title Rapid intracerebroventricular delivery of Cu DOTA etanercept after peripheral administration ... cite journal doi 10.1016 j.drudis.2008.10.005 author Tobinick Edward title Perispinal etanercept ... 3 4 pmid 19027875 cite journal author Tobinick Edward title Perispinal etanercept produces rapid ... in verbal fluency and aphasia following perispinal etanercept in Alzheimer s disease journal ..., Gross H. title Rapid cognitive improvement in Alzheimer s disease following perispinal etanercept administration ... title Perispinal etanercept for treatment of Alzheimer s disease journal Current Alzheimer Research ... last2 Vega first2 CP cite journal author Tobinick E, Davoodifar S. title Efficacy of etanercept delivered ... 2 pmid 12809967 title Targeted etanercept for discogenic neck pain Uncontrolled, open label results ... author Tobinick E. title Targeted etanercept for treatment refractory pain due to bone metastasis two ... more details
to etanercept and placebo in several double blind trials. The Psoriasis Area Severity Index PASI ..., 40 56 under etanercept, and 7 under placebo reached PASI reduction of at least 75 . ref http ... more details
drugbox IUPAC name CAS number 330988 75 5 ATC prefix none ATC suffix PubChem DrugBank KEGG D05393 C 502 H 758 N 154 O 165 S 16 molecular weight 12,103 g mol protein part bioavailability N A metabolism elimination half life excretion pregnancy category legal status investigational routes of administration subcutaneous injection Pegsunercept is a pharmaceutical drug drug for the treatment of rheumatoid arthritis . As of 2010 1 , Phase II clinical trial s have been completed. ref ClinicalTrialsGov NCT00037700 Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis ref ref ClinicalTrialsGov NCT00111423 Evaluating the Safety of Extended Treatment With Pegsunercept PEG sTNF RI in Subjects With Rheumatoid Arthritis RA ref ref name Furst pmid 16331754 ref It is being developed by Amgen . Similarly to etanercept , pegsunercept is a soluble CD120 tumor necrosis factor receptor . Pegsunercept is a PEGylated protein. ref name Furst References reflist Immunosuppressants Category TNF alpha inhibitors Category Immunosuppressants antineoplastic drug stub ... more details
with etanercept in the treatment of moderate to severe plaque psoriasis. ref name Griffiths ... and Etanercept for Moderate to Severe Psoriasis journal The New England Journal of Medicine N Engl ... compared to high dose etanercept. ref name Griffiths It also demonstrated the clinical benefit of ustekinumab among patients who failed to respond to etanercept. ref name Griffiths Ustekinumab is approved ... comparing etanercept and ustekinumab. The entanercept group received subcutaneous injections ... better than the etanercept group, 57 of whom saw such improvement. Dr. Alan Menter, chairman of psoriasis ... more details
, another TNF neutralizing medication, etanercept Enbrel , is worse than a placebo in Crohn s disease ... cell type mediating inflammation, but etanercept does not have this activity, now it is generally ... but not etanercept induces apoptosis in lamina propria T lymphocytes from patients with Crohn s disease ... Simponi , adalimumab Humira , and certolizumab pegol Cimzia . Etanercept also binds and inhibits ... 2001 month March accessdate 2009 11 15 doi 10.1056 NEJM200103223441207 pmid 11259725 ref Etanercept ... of its modified form, cannot neutralize receptor bound TNF . ref Etanercept product labeling ref .... ref Etanercept, Adalimumab and Infliximab product labeling ref Although the clinical significance ... Remicade , etanercept Enbrel , and adalimumab Humira , these drugs are in the class of immunosuppressants ... on studies in AS, the results suggest that infliximab, etanercept , and adalimumab have the potential ... who have had an inadequate response to NSAID level 1a, grade A . The anti TNF agents infliximab and etanercept ... more details
. Treatments directed at tumour necrosis factor Tumor necrosis factors TNF infliximab , etanercept ... factor alpha and clinical efficacy of the TNF Inhibitor Etanercept in a patient with PAPA syndrome. J ... more details
The BASDAI is important because it is a validated diagnostic test which allows a physician usually a rheumatologist to determine the effectiveness of a current drug therapy, or the need to institute a new drug therapy for the treatment of ankylosing spondylitis . The BASDAI consists of a one through 10 scale measuring discomfort, pain, and fatigue one being no problem and 10 being the worst problem in response to 6 questions pertaining to the 5 major symptoms of Ankylosing Spondylitis AS Fatigue medical Spinal pain Joint pain or swelling Areas of localized tenderness also called enthesitis , or inflammation of tendons and ligaments Morning stiffness duration Morning stiffness severity To give each symptom equal weighting, the average of the two scores relating to morning stiffness is taken. The resulting 0 to 50 score is divided by 5 to give a final 0 10 BASDAI score. Scores of 4 or greater suggest suboptimal control of disease, and patients with scores of 4 or greater are usually good candidates for either a change in their medical therapy, eligible for treatment with powerful biologic therapies such as etanercept , infliximab and adalimumab , or may be eligible for enrollment in clinical trials evaluating new drug therapies directed at Ankylosing Spondylitis. History Garrett and coworkers writing in the http www.ncbi.nlm.nih.gov entrez query.fcgi?cmd Retrieve&db pubmed&dopt Abstract&list uids 7699630 Journal of Rheumatology in December 1994 described a self administered 6 question measurement tool which was to become the gold standard for measuring and evaluating disease activity in Ankylosing Spondylitis AS . This validated tool is the BASDAI, or the Bath Ankylosing Spondylitis Disease Activity Index. A research team consisting of rheumatologist s, physiotherapist s, and research associates with a special interest in AS developed the index in Bath, England , hence the reason for Bath in the name. Validation BASDAI is a quick and simple index taking between 30 sec ... more details
Biological response modifers , also known as BRM s, are substances that the human body produces naturally, as well as something that scientists can create in a lab. These substances arouse the body s response to an infection. Some of these are used to treat arthritis, cancer, and some other diseases. Biologics include Monoclonal antibodies, Interleukin 2, Interferon, various types of colony stimulating factors CSF, GM CSF, G CSF Immunotherapy makes use of BRMs to enhance the activity of the immune system to increase the body s natural defense mechanisms against cancer ref http www.cancerquest.org index.cfm?page 186 ref whereas BRMs for rheumatoid arthritis aim to reduce inflammation. Some of the effects of BRMs include nausea and vomiting, diarrhea , loss of appetite , fever and chills, muscle aches, weakness, skin rash, an increased tendency to bleed, or swelling. Citation needed date October 2008 Abciximab Mechanism of action A monoclonal antibody that binds to the glycoprotein receptor IIb IIIa on activated platelets, preventing aggregation. Clinical use Acute coronary syndrome s, percutaneous transluminal coronary angioplasty. Toxicity Bleeding, thrombocytopenia . Etanercept Enbrel Mechanism of action Recombinant form of human TNF receptor that binds Tumor necrosis factors TNF . Clinical use Rheumatoid arthritis , psoriasis , ankylosing spondylitis . Infliximab Remicade Mechanism of action A monoclonal antibody to Tumor necrosis factors TNF , proinflammatory cytokine. Clinical use Crohn s disease , rheumatoid arthritis , ankylosing spondylitis . Toxicity Respiratory infection , fever , hypotension . Predisposes to infections reactivation of latent TB . Rituximab Rituxan Mechanism of action A monoclonal antibody to CD20 surface immunoglobulin. Clinical use Lymphoma Trastuzumab Herceptin Mechanism of action A monoclonal antibody against HER2 neu erb B2 . Helps kill breast cancer cells that overexpress HER 2, possibly through antibody dependent cytotoxicity. Clinic ... more details
Taxobox color lightgrey name Rothia dentocariosa regnum Bacterium Bacteria phylum classis ordo familia genus Rothia species dentocariosa Rothia dentocariosa is a species of gram positive bacteria gram positive , round to rod shaped bacteria that is part of the normal Oral microbiology community of microbes residing in the mouth and respiratory tract . First isolated from dental caries , Rothia dentocariosa is largely benign, but does very rarely cause disease. The most common Rothia infection is endocarditis , typically in people with underlying heart valve disorders. ref name Ricaurte Cite pmid 11332915 ref Literature case reports show other tissues that are rarely infected include the peritoneum , ref name pmid18159489 cite journal author Morris SK, Nag S, Suh KN, A Evans G title Recurrent chronic ambulatory peritoneal dialysis associated infection due to rothia dentocariosa journal Can J Infect Dis Med Microbiol volume 15 issue 3 pages 171 3 year 2004 month May pmid 18159489 pmc 2094970 doi url ref , tonsils ref name tonsils Cite pmid 15876953 ref , lung ref name Ricaurte , cornea ref name cornea Cite pmid 17133072 ref , inner layers of the eye Endophthalmitis ref name endophthalmitis Cite pmid 11757983 ref and brain and intercranial tissues ref name Ricaurte . It has been implicated in periodontal disease , and one hypothesis is that Rothia periodontal disease, or dental procedures in turn, may be first steps in the infection of other tissues ref name Ricaurte . One case reports on a fatal Rothia dentocariosa infection of a fetus in utero ref name fetalinfection Cite pmid 17980173 ref . Another reports the bacterium was responsible for septic arthritis in the knee of a person treated with etanercept for rheumatoid arthritis . ref name Favero Cite pmid 19966198 ref Like other Rothia infections reported in the literature, once the cause of infection was identified, this responded fully to treatment with antibiotics . Rothia infections may be treated with penicilli ... more details
perispinal etanercept off label, an anti Tumor necrosis factor TNF treatment strategy also used for Alzheimer s , was recently reported ref cite journal author Tobinick E title Perispinal etanercept ... perispinal etanercept. http www.brain.northwestern.edu ppa index.html from the Northwestern Cognitive ... more details
necrosis factors TNF inhibitor competitors, infliximab and etanercept , has proven versatile in its ... Etanercept References Reflist golimumab monthly External links http www.humira.com HUMIRA Official site ... more details
2006 pmid 16865867 cite journal author Krell J title Use of alefacept and etanercept in 3 patients whose psoriasis failed to respond to etanercept. journal J Am Acad Dermatol volume 54 issue 6 pages ... more details
pharmaceuticals are under investigation to treat Alzheimer s disease. Etanercept A 2006 pilot study ... s disease after treatment with etanercept , a Tumor necrosis factor alpha receptor fusion protein ... 8 issue 2 pages 25 year 2006 pmid 16926764 doi pmc 1785182 ref Etanercept was administered by perispinal ... cite journal author Griffin WS title Perispinal etanercept potential as an Alzheimer therapeutic journal ... patients has commenced. ref cite journal author Tobinick E title Perispinal etanercept for treatment ... doi 10.2174 156720507783018217 ref A study published in 2008 of etanercept, administered to a single ... Rapid cognitive improvement in Alzheimer s disease following perispinal etanercept administration ... more details
with DMARDs. Anakinra should not be used in combination with anti TNF agents such as etanercept ... of serious infections and an increased risk of neutropenia have been seen when anakinra and etanercept ... and etanercept did not provide any additional benefit to the patients. Methotrexate Methotrexate has ... more details
List of drugs E Et et eta etacepride International Nonproprietary Name INN etacrynic acid International Nonproprietary Name INN etafedrine International Nonproprietary Name INN etafenone International Nonproprietary Name INN etalocib United States Adopted Name USAN etamicastat International Nonproprietary Name INN etaminile International Nonproprietary Name INN etamiphylline International Nonproprietary Name INN etamivan International Nonproprietary Name INN etamocycline International Nonproprietary Name INN etamsylate International Nonproprietary Name INN etanercept etanidazole International Nonproprietary Name INN etanterol International Nonproprietary Name INN etaqualone International Nonproprietary Name INN etaracizumab United States Adopted Name USAN , International Nonproprietary Name INN etarotene International Nonproprietary Name INN etasuline International Nonproprietary Name INN etazepine International Nonproprietary Name INN etazolate International Nonproprietary Name INN ete etebenecid International Nonproprietary Name INN eterobarb International Nonproprietary Name INN etersalate International Nonproprietary Name INN eth etha ethr ethacridine International Nonproprietary Name INN ethambutol International Nonproprietary Name INN Ethamide Ethamolin ethanol , a type of alcohol ethaverine International Nonproprietary Name INN ethchlorvynol International Nonproprietary Name INN ethenzamide International Nonproprietary Name INN ethinamate International Nonproprietary Name INN ethinylestradiol International Nonproprietary Name INN ethiodized oil 131 I International Nonproprietary Name INN Ethiodol ethionamide International Nonproprietary Name INN ethisterone International Nonproprietary Name INN Ethmozine ethoheptazine International Nonproprietary Name INN ethomoxane International Nonproprietary Name INN ethosuximide International Nonproprietary Name INN ethotoin International Nonproprietary Name INN ethoxazorutoside International Nonproprietary Name INN Ethra ... more details
Encyclopedia
top
